BRISTOL-MYERS SQUIBB COMPANY (BMY) Free cash flow
- Free cash flow · 12 months (USD): Value $11.44B; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 23.26%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $11.44B | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $12.78B − $1.34B ≈ $11.44B |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 23.26% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $11.44B ÷ $49.19B × 100 ≈ 23.26% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $12.78B | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.38× | Operating cash flow / net income. Period ending 2026-06-30. $12.78B ÷ $9.28B ≈ 1.38× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 12.78B USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 1.34B USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 11.44B USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 49.19B USD | |
| Quarter-end shares | (m) | |
| Net income | 9.28B USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $11.44B | (m) | $12.78B | $1.34B | (m) | $49.19B | (m) | $9.28B | (m) | (m) | 23.26% | 1.38× |
| 2026-03-31 | $11.91B | (m) | $13.31B | $1.40B | (m) | $48.48B | (m) | $7.28B | (m) | (m) | 24.56% | 1.83× |
| 2025-12-31 | $12.85B | (m) | $14.16B | $1.31B | (m) | $48.19B | (m) | $7.05B | (m) | (m) | 26.65% | 2.01× |
| 2025-09-30 | $15.30B | (m) | $16.62B | $1.32B | (m) | $48.03B | (m) | $6.04B | (m) | (m) | 31.86% | 2.75× |
| 2025-06-30 | $14.58B | (m) | $15.90B | $1.32B | (m) | $47.70B | (m) | $5.05B | (m) | (m) | 30.56% | 3.15× |
| 2025-03-31 | $13.09B | (m) | $14.31B | $1.22B | (m) | $47.64B | (m) | $5.42B | (m) | (m) | 27.47% | 2.64× |
| 2024-12-31 | $13.94B | (m) | $15.19B | $1.25B | (m) | $48.30B | (m) | $-8.95B | (m) | (m) | 28.87% | -1.70× |
| 2024-09-30 | $13.80B | (m) | $15.00B | $1.20B | (m) | $47.44B | (m) | $-7.26B | (m) | (m) | 29.10% | -2.07× |
| 2024-06-30 | $12.95B | (m) | $14.16B | $1.22B | (m) | $46.51B | (m) | $-6.54B | (m) | (m) | 27.83% | -2.17× |
| 2024-03-31 | $12.51B | (m) | $13.72B | $1.22B | (m) | $45.53B | (m) | $-6.15B | (m) | (m) | 27.47% | -2.23× |
| 2023-12-31 | $12.65B | (m) | $13.86B | $1.21B | (m) | $45.01B | (m) | $8.03B | (m) | (m) | 28.11% | 1.73× |
| 2023-09-30 | $11.69B | (m) | $12.91B | $1.23B | (m) | $44.94B | (m) | $8.29B | (m) | (m) | 26.01% | 1.56× |
| 2023-06-30 | $10.72B | (m) | $11.85B | $1.13B | (m) | $45.19B | (m) | $7.96B | (m) | (m) | 23.72% | 1.49× |
| 2023-03-31 | $11.08B | (m) | $12.22B | $1.14B | (m) | $45.85B | (m) | $7.31B | (m) | (m) | 24.17% | 1.67× |
| 2022-12-31 | $11.95B | (m) | $13.07B | $1.12B | (m) | $46.16B | (m) | $6.33B | (m) | (m) | 25.88% | 2.07× |
| 2022-09-30 | $12.72B | (m) | $13.82B | $1.09B | (m) | $46.74B | (m) | $6.68B | (m) | (m) | 27.23% | 2.07× |
| 2022-06-30 | $14.28B | (m) | $15.40B | $1.11B | (m) | $47.14B | (m) | $6.62B | (m) | (m) | 30.29% | 2.33× |
| 2022-03-31 | $15.14B | (m) | $16.20B | $1.05B | (m) | $46.96B | (m) | $6.25B | (m) | (m) | 32.24% | 2.59× |
| 2021-12-31 | $15.23B | (m) | $16.21B | $973.00M | (m) | $46.38B | (m) | $6.99B | (m) | (m) | 32.84% | 2.32× |
| 2021-09-30 | $14.57B | (m) | $15.51B | $936.00M | (m) | $45.47B | (m) | $-5.41B | (m) | (m) | 32.04% | -2.87× |
| 2021-06-30 | $11.69B | (m) | $12.51B | $819.00M | (m) | $44.38B | (m) | $-5.08B | (m) | (m) | 26.33% | -2.46× |
| 2021-03-31 | $13.20B | (m) | $13.94B | $740.00M | (m) | $42.81B | (m) | $-6.22B | (m) | (m) | 30.83% | -2.24× |
| 2020-12-31 | $13.30B | (m) | $14.05B | $753.00M | (m) | $42.52B | (m) | $-9.02B | (m) | (m) | 31.28% | -1.56× |
| 2020-09-30 | $11.70B | (m) | $12.42B | $721.00M | (m) | $39.40B | (m) | $-44.00M | (m) | (m) | 29.70% | -282.27× |
| 2020-06-30 | $12.00B | (m) | $12.76B | $758.00M | (m) | $34.86B | (m) | $-563.00M | (m) | (m) | 34.42% | -22.66× |
| 2020-03-31 | $9.75B | (m) | $10.57B | $818.00M | (m) | $31.01B | (m) | $954.00M | (m) | (m) | 31.46% | 11.08× |
| 2019-12-31 | $7.23B | (m) | $8.07B | $836.00M | (m) | $26.14B | (m) | $3.44B | (m) | (m) | 27.66% | 2.35× |
| 2019-09-30 | $7.58B | (m) | $8.46B | $875.00M | (m) | $24.17B | (m) | $5.66B | (m) | (m) | 31.37% | 1.50× |
| 2019-06-30 | $6.27B | (m) | $7.18B | $909.00M | (m) | $23.86B | (m) | $6.20B | (m) | (m) | 26.29% | 1.16× |
| 2019-03-31 | $5.24B | (m) | $6.16B | $916.00M | (m) | $23.29B | (m) | $5.14B | (m) | (m) | 22.50% | 1.20× |
| 2018-12-31 | $4.99B | (m) | $5.94B | $951.00M | (m) | $22.56B | (m) | $4.92B | (m) | (m) | 22.11% | 1.21× |
| 2018-09-30 | $3.71B | (m) | $4.63B | $915.00M | (m) | $22.04B | (m) | $1.43B | (m) | (m) | 16.85% | 3.23× |
| 2018-06-30 | $4.11B | (m) | $5.06B | $953.00M | (m) | $21.60B | (m) | $376.00M | (m) | (m) | 19.02% | 13.46× |
| 2018-03-31 | $4.59B | (m) | $5.59B | $1.00B | (m) | $21.04B | (m) | $919.00M | (m) | (m) | 21.80% | 6.08× |
| 2017-12-31 | $4.22B | (m) | $5.28B | $1.05B | (m) | $20.78B | (m) | $1.01B | (m) | (m) | 20.31% | 5.24× |
| 2017-09-30 | $4.22B | (m) | $5.39B | $1.17B | (m) | $20.57B | (m) | $4.23B | (m) | (m) | 20.52% | 1.28× |
| 2017-06-30 | $3.83B | (m) | $5.08B | $1.25B | (m) | $20.24B | (m) | $4.59B | (m) | (m) | 18.94% | 1.11× |
| 2017-03-31 | $2.67B | (m) | $3.94B | $1.26B | (m) | $19.96B | (m) | $4.84B | (m) | (m) | 13.40% | 0.81× |
| 2016-12-31 | $1.64B | (m) | $2.85B | $1.22B | (m) | $19.43B | (m) | $4.46B | (m) | (m) | 8.42% | 0.64× |
| 2016-09-30 | $904.00M | (m) | $2.03B | $1.13B | (m) | $18.47B | (m) | $3.37B | (m) | (m) | 4.89% | 0.60× |
| 2016-06-30 | $138.00M | (m) | $1.16B | $1.02B | (m) | $17.62B | (m) | $2.87B | (m) | (m) | 0.78% | 0.40× |
| 2016-03-31 | $-106.00M | (m) | $820.00M | $926.00M | (m) | $16.91B | (m) | $1.57B | (m) | (m) | -0.63% | 0.52× |
| 2015-12-31 | $1.01B | (m) | $1.83B | $820.00M | (m) | $16.56B | (m) | $1.56B | (m) | (m) | 6.11% | 1.17× |
| 2015-09-30 | $1.07B | (m) | $1.79B | $726.00M | (m) | $16.53B | (m) | $1.77B | (m) | (m) | 6.45% | 1.01× |
| 2015-06-30 | $1.57B | (m) | $2.17B | $599.00M | (m) | $16.38B | (m) | $1.79B | (m) | (m) | 9.60% | 1.21× |
| 2015-03-31 | $2.61B | (m) | $3.16B | $544.00M | (m) | $16.11B | (m) | $2.25B | (m) | (m) | 16.22% | 1.40× |
| 2014-12-31 | $2.62B | (m) | $3.15B | $526.00M | (m) | $15.88B | (m) | $2.00B | (m) | (m) | 16.51% | 1.57× |
| 2014-09-30 | $3.45B | (m) | $3.99B | $535.00M | (m) | $16.06B | (m) | $2.72B | (m) | (m) | 21.49% | 1.47× |
| 2014-06-30 | $3.58B | (m) | $4.14B | $552.00M | (m) | $16.21B | (m) | $2.69B | (m) | (m) | 22.12% | 1.54× |
| 2014-03-31 | $4.05B | (m) | $4.59B | $540.00M | (m) | $16.36B | (m) | $2.89B | (m) | (m) | 24.75% | 1.59× |
| 2013-12-31 | $3.01B | (m) | $3.54B | $537.00M | (m) | $16.39B | (m) | $2.56B | (m) | (m) | 18.36% | 1.38× |
| 2013-09-30 | $2.46B | (m) | $2.97B | $512.00M | (m) | $16.14B | (m) | $2.76B | (m) | (m) | 15.24% | 1.08× |
| 2013-06-30 | $5.98B | (m) | $6.50B | $525.00M | (m) | $15.81B | (m) | $1.36B | (m) | (m) | 37.81% | 4.78× |
| 2013-03-31 | $5.59B | (m) | $6.13B | $540.00M | (m) | $16.20B | (m) | $1.47B | (m) | (m) | 34.48% | 4.17× |
| 2012-12-31 | $6.39B | (m) | $6.94B | $548.00M | (m) | $17.62B | (m) | $1.96B | (m) | (m) | 36.28% | 3.54× |
| 2012-09-30 | $7.17B | (m) | $7.67B | $507.00M | (m) | $18.88B | (m) | $1.89B | (m) | (m) | 37.95% | 4.07× |
| 2012-06-30 | $4.33B | (m) | $4.79B | $454.00M | (m) | $20.49B | (m) | $3.57B | (m) | (m) | 21.14% | 1.34× |
| 2012-03-31 | $4.33B | (m) | $4.75B | $415.00M | (m) | $21.48B | (m) | $3.82B | (m) | (m) | 20.16% | 1.24× |
| 2011-12-31 | $4.47B | (m) | $4.84B | $367.00M | (m) | $21.24B | (m) | $3.71B | (m) | (m) | 21.06% | 1.30× |
| 2011-09-30 | $4.51B | (m) | $4.87B | $358.00M | (m) | $20.90B | (m) | $3.34B | (m) | (m) | 21.57% | 1.46× |
| 2011-06-30 | $4.19B | (m) | $4.55B | $363.00M | (m) | $20.35B | (m) | $3.32B | (m) | (m) | 20.58% | 1.37× |
| 2011-03-31 | $4.14B | (m) | $4.51B | $370.00M | (m) | $19.69B | (m) | $3.35B | (m) | (m) | 21.02% | 1.35× |
| 2010-12-31 | $4.07B | (m) | $4.49B | $424.00M | (m) | $19.48B | (m) | $3.10B | (m) | (m) | 20.87% | 1.45× |
| 2010-09-30 | $3.75B | (m) | $4.24B | $495.00M | (m) | $19.41B | (m) | $10.64B | (m) | (m) | 19.30% | 0.40× |
| 2010-06-30 | $3.75B | (m) | $4.33B | $575.00M | (m) | $19.40B | (m) | $10.66B | (m) | (m) | 19.36% | 0.41× |
| 2010-03-31 | $3.42B | (m) | $4.08B | $658.00M | (m) | $19.29B | (m) | $10.72B | (m) | (m) | 17.72% | 0.38× |
| 2009-12-31 | $3.33B | (m) | $4.07B | $730.00M | (m) | $18.81B | (m) | $10.61B | (m) | (m) | 17.73% | 0.38× |
| 2009-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $2.77B | (m) | $3.71B | $941.00M | (m) | $17.71B | (m) | $5.25B | (m) | (m) | 15.61% | 0.71× |
| 2008-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-12-31 | $2.31B | (m) | $3.15B | $843.00M | (m) | $15.62B | (m) | $2.17B | (m) | (m) | 14.79% | 1.46× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |